You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 25, 2024

CLINICAL TRIALS PROFILE FOR BENLYSTA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BENLYSTA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01160666 ↗ Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome Completed Human Genome Sciences Inc. Phase 2 2010-03-01 Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by an increase in BAFF (BLyS) levels and a resulting B cell hyperactivity. B cells are involved in the pathogenesis of SS in both systemic and glandular features, and B cell downregulation may lead to a decrease of disease activity. Moreover, pathogenesis of SS is closed to that of Systemic lupus erythematosus, where Belimumab has been proven to be effective.
NCT01160666 ↗ Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome Completed Assistance Publique - Hôpitaux de Paris Phase 2 2010-03-01 Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by an increase in BAFF (BLyS) levels and a resulting B cell hyperactivity. B cells are involved in the pathogenesis of SS in both systemic and glandular features, and B cell downregulation may lead to a decrease of disease activity. Moreover, pathogenesis of SS is closed to that of Systemic lupus erythematosus, where Belimumab has been proven to be effective.
NCT01532310 ↗ Belimumab (BENLYSTA®) Pregnancy Registry Recruiting PPD 2012-07-16 This global Belimumab Pregnancy Registry will collect prospective data on pregnancies and pregnancy outcomes on a voluntary basis in women with systemic lupus erythematosus (SLE) who have received commercially supplied belimumab within the 4 months prior to and/or during pregnancy. The registry will also evaluate outcomes of infants born to mothers who were exposed to belimumab within the 4 months prior to and/or during pregnancy. This registry will add to the current clinical experience with belimumab and will complement reproductive data from animal toxicology studies. It will also assist clinicians in weighing the potential risks against the benefits of treatment for individual patients with SLE. GlaxoSmithKline (GSK) will sponsor the Belimumab Pregnancy Registry in countries where it holds Marketing Authorization.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BENLYSTA

Condition Name

Condition Name for BENLYSTA
Intervention Trials
Systemic Lupus Erythematosus 2
Systemic Sclerosis 2
Lupus Nephritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BENLYSTA
Intervention Trials
Lupus Erythematosus, Systemic 2
Sclerosis 2
Scleroderma, Systemic 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BENLYSTA

Trials by Country

Trials by Country for BENLYSTA
Location Trials
United States 18
France 2
Belgium 1
Singapore 1
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BENLYSTA
Location Trials
New York 4
Ohio 2
Missouri 2
Alabama 2
North Carolina 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BENLYSTA

Clinical Trial Phase

Clinical Trial Phase for BENLYSTA
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 1
Phase 2 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BENLYSTA
Clinical Trial Phase Trials
Completed 6
Recruiting 6
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BENLYSTA

Sponsor Name

Sponsor Name for BENLYSTA
Sponsor Trials
GlaxoSmithKline 9
Human Genome Sciences Inc. 2
Assistance Publique - Hôpitaux de Paris 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BENLYSTA
Sponsor Trials
Other 21
Industry 13
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.